QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

NNNN

QT—Anbio Biotechnology Class A Ordinary Shares
NASDAQ·Healthcare·Medical - Instruments & Supplies·Germany
Latest market price
16.64
+0.78+4.92%
OverviewShort InterestFilings
NNNNAnbio Biotechnology Class A Ordinary Shares·NASDAQ
OverviewShort InterestFilings
16.64+4.92%
TA
Loading chart...
Screen all →
BDX+1.67%$143.98ALC+0.84%$64.68MDLN-1.32%$35.94WST+1.35%$327.95COO+1.32%$65.91BAX+2.58%$19.89ATR+0.28%$120.32RGEN-1.15%$132.02
Snapshot
Index-P/E-EPS (ttm)0.22
Insider Own-
Shs Outstand43.89M
Perf Week1.22%
Market Cap2.28BForward P/E-EPS next Y-Insider Trans-Shs Float-Perf Month-48.55%
Enterprise Value-PEG-EPS next Q-Inst Own-Short Float-Perf Quarter-22.68%
Income-P/S-EPS this Y-Inst Trans-Short Ratio-Perf Half Y-40.59%
Sales-P/B-EPS next Y-ROA-Short Interest-Perf YTD-44.66%
Book/sh0.68P/C-EPS next 5Y-ROE-52W High55.65 -70.10%Perf Year67.24%
Cash/sh0.27P/FCF-EPS past 3/5Y31.98% -ROIC-52W Low9.20 80.87%Perf 3Y-
Dividend Est.-EV/EBITDA-Sales past 3/5Y-25.31% -Gross Margin-Volatility8.21% 9.50%Perf 5Y-
Dividend TTM-EV/Sales-EPS Y/Y TTM-Oper. Margin-ATR (14)2.92Perf 10Y-
Dividend Ex-Date-Quick Ratio-Sales Y/Y TTM137.50%Profit Margin-RSI (14)32.41Recom-
Dividend Gr. 3/5Y-Current Ratio-EPS Q/Q-SMA20-31.45%Beta0.70Target Price-
Payout-Debt/Eq-Sales Q/Q25.00%SMA50-36.73%Rel Volume0.67Prev Close15.86
Employees27LT Debt/Eq-Earnings-SMA200-40.87%Avg Volume27.29KPrice16.64
IPO DateFeb 19, 2025Option/ShortYes / YesEPS/Sales Surpr.-Net Debt/EBITDA-Volume18,166Change4.92%
Latest News
Jun-18-26
Jun-18-2606:02AM
Top 3 Health Care Stocks You'll Regret Missing In Q2Benzinga
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
Total Revenue19108
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A312
Gross Profit1596
Selling, General and Administrative Excl. Other623
Research and Development
000
Other Operating Expense001
Operating Income972
Interest Expense
000
Unusual Expense
———
Non-Operating Income (Expense)
000
Net Income Before Taxes1072
Income Taxes
000
Consolidated Net Income1072
Net Income From Continuing Operations1072
Net Income1072
EPS (Recurring)0.220.160.06
EPS (Basic, Before Extraordinaries)0.220.160.06
EPS (Diluted)0.220.160.06
EBITDA1073
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio75.64187.94—
Price To Sales Ratio38.53132.31—
Gross Margin78.9590.0075.00
Operating Margin47.3770.0025.00
Net Margin52.6370.0025.00
Shares Outstanding444442
Market Capitalization7321,323—
Operating Lease Expense
———
Insider Trading Volume
$18.57$17.22$15.88$14.53$13.18● Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR